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Abstract
The effects of transmembrane electric potential difference and ionic strength on the permeation of tryptamine and indoleacetic acid across
a Caco-2 cell monolayer were examined. A decrease in the transmembrane electric potential difference caused by the addition of potassium
ion to the transport buffer had no effect on the permeation rate of either compound. On the other hand, an increase in ionic strength resulted in
a decrease in the permeation rate of tryptamine and an increase in the permeation rate of indoleacetic acid. The changes in the permeation rate
with changes in the ionic strength were correlated with the membrane surface potential monitored by 1-anilino-8-naphthalenesulfonic acid
(ANS), a fluorescent probe. We tested these effects using several other cationic and anionic compounds. These effects of ionic strength were
found to be common to all drugs tested. The compound that showed a relatively lower permeation rate was given relatively stronger effect.
The possibility of overestimation or underestimation caused by these effects should be considered when the permeation of an ionic compound
is evaluated using a cell monolayer system. D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Electrostatic interaction between ionic drugs and a bio-
logical or artificial membrane affect the permeation rate of
the drugs across the membrane. We previously reported that
the rate of uptake of tryptamine, a cationic compound, into
rat intestinal brush-border membrane (BBM) vesicles was
stimulated in the presence of inside-negative transmembrane
electric potential difference [1]. This electrophoretic perme-
ation was also observed when an artificial membrane (lip-
osomes) was used [2]. Moreover, this phenomenon was
common to many cationic compounds [3,4]. The permeation
of these cationic compounds was also affected by membrane
surface charge and ionic strength. The permeation rate
increased when the membrane surface negative charge of
liposomes was increased by adding dipalmitoyl-DL-a-phos-
phatidylserine to the lipid bilayer and also when the ionic
strength of a medium of suspended BBM vesicles was
decreased [2]. On the other hand, the permeation rates of
anionic compounds such as benzylpenicillin, cefixime, and
benzyloxyindoleacetic acid decreased with an increase in
membrane surface negative charge, whereas transmembrane
electric potential difference had no effect [5–7].
Intestinal epithelial cells have negatively charged BBMs
and transmembrane electric potential difference (f 60
mV). Therefore, changes in ionic strength and transmem-
brane electric potential difference could affect the perme-
ation rates of these cationic and anionic compounds through
the epithelial cell layer. Caco-2 cells, a human colon
adenocarcinoma cell line, have been used as a model to
study the intestinal absorption of drugs because they form a
monolayer of enterocyte-like cells that have functional
properties of the epithelium [8]. This cell line has been
shown to be a good model for studying intestinal drug
absorption [9]. In this study, we used this cell line to study
the permeation rates of drugs through a monolayer of
epithelial cells.
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The aim of this study is to clarify the degree to which the
abovementioned transmembrane electric potential differ-
ence-dependent and ionic strength-dependent mechanisms
participate in the permeation of drugs through the intestinal
epithelium, because it is still not clear whether these mecha-
nisms are actually work in the permeation through epithelial
cells (transcellular transport). The concentration of potas-
sium ions in the transport buffer was changed to determine
the effects of transmembrane electric potential difference
and ionic strength on the permeation of drugs. Changes in
the concentration of potassium ions would cause changes in
the transmembrane electric potential difference.
2. Materials and methods
2.1. Materials
[3H]Glycylsarcosine (92.8 GBq/mmol) was purchased
from Moravek Biochemicals Inc. (Brea, CA). Atenolol,
benzyloxytryptamine hydrochloride, imipramine hydro-
chloride, metoprolol tartrate, pindolol, promethazine hydro-
chloride, ritodrine hydrochloride, enoxacin, 5-benzyloxy-
indole-3-acetic acid, naproxen, tolmetin sodium dihydrate,
and fluorescein isothiocyanate–dextran 4000 (FITC–dex-
tran 4000) were purchased from Sigma Chemical Co. (St.
Louis, MO). Chlorpromazine hydrochloride, gramine, phe-
niramine maleate, acetanilide, antipyrine, caffeine, 3-indo-
leacetic acid, and salicylic acid were purchased from Wako
Pure Chemical Industries Ltd. (Osaka, Japan). 4-Phenyl-
butylamine was obtained from Aldrich Chemical Co. (Mil-
waukee, WI). 1-Anilino-8-naphthalenesulfonic acid (ANS)
hemi-magnesium salt and tryptamine hydrochloride were
obtained from Nacalai Tesque (Kyoto, Japan). Metiazic acid
was a gift from Mect Co., Ltd. (Tokyo, Japan). The human
colon carcinoma cell line Caco-2 was obtained from the
American Type Culture Collection (Rockville, MD). High-
glucose Dulbecco’s modified Eagle’s medium (DMEM),
fetal bovine serum, MEM nonessential amino acids, L-
glutamine, and trypsine were purchased from Life Technol-
ogies, Inc. (Gaithersburg, MD). All other chemicals were of
the highest grade available.
2.2. Cell culture
Caco-2 cells (passage number 32–60) were cultured in
DMEM supplemented with 10% fetal bovine serum, 1%
MEM nonessential amino acids, and 4 mM L-glutamnine.
The cells were maintained in 75-cm2 flasks and trypsinized
(0.25% trypsin, 0.02% EDTA in Ca2 + - and Mg2 + -free
Hank’s balanced salt solution (HBSS)) when they reached
confluence. For the experiment to measure the uptake into
the cells, 2 105 cells were seeded per well in 6-well
culture plates (Becton Dickinson, Franklin Lakes, NJ) and
then used on the 14th day after seeding. For the measure-
ment of transport through a monolayer of the cells, 6 105
cells were seeded on a culture insert (polycarbonate filter;
pore size, 3.0 mm; 4.71 cm2) inside a transwell cell culture
chamber (Costar, Cambridge, MA) and used on the 20th day
of seeding. For the preparation of BBM vesicles, cells were
cultured for 14 days in 10-cm dishes (Becton Dickinson).
2.3. Buffers for uptake and transport experiments
The compositions of the buffers on the apical side used
for the uptake and the transport experiments are shown in
Table 1. In this study, we reduced the concentrations of the
salts in the apical side buffers in order to cause changes in
the membrane surface potential by varying ionic strength
effectively. The ionic strength was varied by the addition of
potassium gluconate. The osmolality and the ionic strength
were compensated with D-mannitol and choline chloride,
respectively. The pH of the medium was adjusted to 6.0 or
7.4 by 10 mM of either Mes/Tris or Hepes/Tris, respectively.
Unless otherwise stated, the pH of the apical buffer was 6.0.
The composition of the buffer on the basolateral side was 10
Table 1
Composition of apical buffer
Component Varied ionic strength Constant ionic strength
2.5 mM K+ 25 mM K+ 50 mM K+ 125 mM K+ 2.5 mM K+ 25 mM K+ 50 mM K+ 125 mM K+
CaCl2 (AM) 12.6 12.6 12.6 12.6 12.6 12.6 12.6 12.6
KCl (mM) 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5
K-gluconate (mM) 0 22.5 47.5 122.5 0 22.5 47.5 122.5
KH2PO4 (AM) 4.4 4.4 4.4 4.4 4.4 4.4 4.4 4.4
MgSO4 (AM) 8.1 8.1 8.1 8.1 8.1 8.1 8.1 8.1
NaCl (mM) 15 15 15 15 15 15 15 15
Choline chloride (mM) 0 0 0 0 122.5 100 75 0
Mes or Hepes (mM) 10 10 10 10 10 10 10 10
D-Mannitol (mM) 257 212 162 11.9 11.9 11.9 11.9 11.9
Na2HPO4 (AM) 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.4
D-Glucose (mM) 25 25 25 25 25 25 25 25
Ionic strength (I) 17.6 40.1 65.1 140 140 140 140 140
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mM Hepes/Tris (pH 7.4), 137 mM NaCl, 5.4 mM KCl, 1.3
mM CaCl2, 0.8 mM MgSO4, 0.44 mM KH2PO4, 0.34 mM
Na2HPO4, and 25 mM D-glucose.
2.4. Uptake experiment
The culture medium was removed and the cells were
washed twice with 2 ml of uptake buffer (Table 1) and pre-
incubated in 2 ml of the buffer at 37 jC for 5 min. Then the
uptake was started by replacing the buffer with 2 ml of the
buffer containing the drug to be tested. At a pre-determined
time, the uptake was terminated by aspiration of the drug
solution. The cells were then washed twice with 2 ml of the
ice-cold buffer. The cells were solubilized with 1 ml of 1 N
NaOH, and 10 Al of an aliquot was used for protein
estimation. The rest of the lysate was neutralized with 990
Al of 1 N HCl and the same volume of uptake buffer. After
centrifugation at 9000 g for 5 min, the concentrations of
drugs in the supernatant were measured.
2.5. Transport experiment
Cultured Caco-2 monolayers with transepithelial electri-
cal resistance of more than 600 V cm2 were used. The cells
were pre-incubated for 5 min at 37 jC in 1.5 ml of apical
buffer and 2.6 ml of basal buffer. Then 0.75 ml of the apical
side buffer was replaced by the same volume of the drug
solution. The culture insert was transferred to the next well
containing fresh basal buffer every 15 min for 1 h. The drug
concentration of each basal buffer was measured and its flux
rate was calculated.
2.6. Preparation of BBM vesicles from Caco-2 cells
Preparation of BBM vesicles from Caco-2 cells was done
on ice or at 4jC according to the method of Inui et al. [10],
who reported the method to prepare BBM vesicles from a
kidney epithelial cell line, LLC-PK1, with some modifica-
tions. The cells were scraped and suspended in 40 ml of
buffer A (100 mM D-mannitol, 5 mM EGTA, 12 mM Tris–
HCl, pH7.1). Then the cells were centrifuged at 200 g for
10 min and resuspended in 40 ml of buffer A. The cells were
disrupted by the nitrogen cavitation method (cell disruption
bomb, Parr Instrument Co., Moline, IL). The cells were
pressurized at 700 psi (49 kg/cm2) for 15 min. The collected
homogenate was diluted with the same volume of distilled
water and homogenized using a Dounce-type homogenizer.
Magnesium chloride was added at the final concentration of
0.625 mM, and the mixture was allowed to stand for 15 min
and then centrifuged at 3000 g for 15 min. The super-
natant was centrifuged at 27,000 g for 30 min, and the
pellet was resuspended in 40 ml of buffer B (50 mM D-
mannitol, 2.5 mM EGTA, 6 mM Tris–HCl, pH 7.1). Then
magnesium precipitation and centrifugation as mentioned
above were repeated. The final pellet was homogenized
using a Dounce-type homogenizer in the same buffers as
those used in the uptake and transport experiments. The
specific activity of alkaline phosphatase, a marker enzyme
of the BBM, of final vesicles was increased by more than
sevenfold compared with the initial homogenate. The val-
idity of membrane vesicles was confirmed by the results of
an uptake experiment. Sodium gradient-dependent uptake of
glutamic acid was observed (not shown).
2.7. Measurement of changes in the surface potential of
Caco-2 BBM vesicles
Changes in the surface potential of Caco-2 BBM vesicles
were monitored by measuring the changes in the fluores-
cence intensity of ANS as described previously [2,5]. The
measurement was carried out at room temperature in a
spectrofluorometer (Hitachi 650-60, Tokyo, Japan) with an
excitation wavelength of 385 nm and an emission wave-
length of 480 nm. To 300 Al of a suspension of membrane
vesicles, 300 Al of dye solution and 600 Al of apical buffer,
the ionic strength of which was varied (Table 1), were
added. The final concentrations of ANS were 0, 12.5, 50,
and 100 AM, and that of BBM vesicles was 0.1 mg protein/
ml.
2.8. Distribution coefficient
The n-octanol-buffer distribution coefficient at pH 6.0
was measured with buffers having various ionic strengths.
The drug solution was shaken with n-octanol at room
temperature for 30 min. After centrifugation at 1500 g
for 5 min, the concentration of the drug in the aqueous phase
was determined.
2.9. Analytical methods
Protein concentration was determined by the method of
Lowry et al. [11] using bovine serum albumin as a standard.
The concentrations of drugs were determined using an
HPLC (Hitachi L-6000) equipped with a Hitachi L-4200H
UV detector and Hitachi F-1050 fluorescence detector.
Separation of drugs was done on a reversed-phase column
Hitachi Gel #3053 except for the case of ritodrine (ERC-
ODS-1160, ERC Inc., Tokyo, Japan). The mobile phase was
basically 20 or 50 mM KH2PO4 containing various concen-
trations (15–70 %) of acetonitrile.
3. Results and discussion
3.1. Viability of Caco-2 cells
In this study, we reduced the concentrations of the ions in
the apical buffers for the uptake and the transport experi-
ments. Since low concentrations of salts, especially Ca2 +
and Mg2 + , might affect the viability of the monolayer of
Caco-2 cells, we measure the transport of FITC–dextran,
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which is widely used as a marker for paracellular perme-
ation. The cumulative amount of the transported FITC–
dextran to the basal side over a period of 60 min was less
than 0.5% of that added to the apical side, and it was almost
the same as the value with the normal buffer. On the other
hand, when a Ca2 + - and Mg2 + -free buffer was used, the
amount of FITC–dextran increased significantly (not
shown). These results suggest that the viability of the
monolayer of Caco-2 cells was maintained in the buffer in
this study even when the concentrations of divalent cations
were reduced.
3.2. Effect of potassium ion concentration on the uptake of
glycylsarcosine
It is widely known that Caco-2 cells express PEPT1, an
electrogenic proton–peptide symporter [12]. To examine the
effect of potassium ions, the transport of [3H]-glycylsarco-
sine, a substrate of PEPT1, was studied. Fig. 1A shows the
effect of potassium ions on the uptake of glycylsarcosine.
When sodium was replaced by potassium, the uptake of
glycylsarcosine decreased by f 50% compared with that in
the presence of sodium. As shown in Fig. 1B, the uptake of
glycylsarcosine was stimulated in the buffer at pH 6.0. At
pH 6.0, the uptake decreased by f 40% when potassium in
the uptake buffer was increased (from 2.5 to 125 mM). This
result suggests that potassium reduces the electrogenic
uptake of glycylsarcosine by decreased transmembrane
electric potential difference and also that the transport
buffers in this study can be used to change the transmem-
brane electric potential difference.
3.3. Effect of potassium ion concentration on the perme-
ation of tryptamine and indoleacetic acid
Fig. 2 shows the effect of potassium ion concentration on
the time course of the permeation of a cationic compound,
tryptramine (Fig. 2A,B), and its carboxylic acid derivative,
indoleacetic acid (Fig. 2C,D), through a Caco-2 cell mono-
layer. When the concentration of potassium ions was
increased from 2.5 to 125 mM and the osmolality was
adjusted with D-mannitol, that is, when the ionic strength
was increased by the addition of potassium ions, the per-
meation rate of tryptamine decreased (Fig. 2A), whereas that
of indoleacetic acid increased (Fig. 2C). On the other hand,
when the osmolality was adjusted with choline chloride (i.e.,
when ionic strength did not change), there was no change in
the permeation rate of either compound. These results
suggest that a change in the transmembrane electric poten-
tial difference caused by potassium ions does not affect the
permeation of the tested compounds, whereas a change in
the ionic strength has significant effects.
3.4. Correlation between changes in ionic strength and
permeation of tryptamine and indoleacetic acid through a
Caco-2 cell monolayer
Fig. 3A and B shows the effects of ionic strength of the
apical buffer on the permeation of tryptamine and indole-
Fig. 1. Effect of potassium ion concentration on the uptake of
glycylsarcosine by Caco-2 cells. (A) The composition of the uptake buffer
was 25 mM Mes/Tris (pH 6.0) containing 140 mM NaCl (or KCl, choline
Cl), 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM MgSO4, 5 mM glucose, and 0.5
AM [3H]glycylsarcosine. (B) The composition of the uptake buffer is shown
in Table 1. The concentration of potassium was changed with potassium
gluconate, and ionic strength was kept constant.
Fig. 2. Effects of potassium concentration of the apical buffer on the
permeation of tryptamine (A, B) and indoleacetic acid (C, D) across Caco-2
cells with (A, C) or without (B, D) change in ionic strength. The amounts of
compounds permeated in the presence of 2.5 mM (o) or 125 mM (.) of
potassium were measured. The concentrations of tryptamine and indole-
acetic acid were 500 AM, and the pH of the apical buffer was 7.4.
Osmolality was adjusted with D-mannitol (A, C; with change in ionic
strength) or choline chloride (B, D; without change in ionic strength). Each
point represents the mean of three measurements. Standard errors are within
the range of the symbols.
Fig. 3. Relationships between ionic strength (I) and permeability of tryp-
tamine (A) and indoleacetic acid (B) across Caco-2 cells. The concentrations
of tryptamine and indoleacetic acid were 500 AM. Ionic strength of the apical
buffer varied with changes in the concentration of potassium gluconate (2.5,
25, 50, and 125 mM), and osmolality was adjusted by adding D-mannitol.
Each point represents the meanF S.E. of three measurements. Some of the
standard errors are within the range of the symbols.
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acetic acid through a monolayer of Caco-2 cells. The ionic
strength was varied with potassium gluconate, and the
osmolality was compensated with D-mannitol. The perme-
ation rate of tryptamine decreased with an increase in ionic
strength, whereas that of indoleacetic acid increased. Fig. 4
shows the effects of ionic strength of the apical buffer on the
uptake of tryptamine and indoleacetic acid by Caco-2 cells.
The uptake of tryptamine decreased with an increase in the
ionic strength (Fig. 4A). This result is consistent with our
previous result showing a correlation between the uptake of
tryptamine by rat intestinal BBM vesicles and changes in
the ionic strength that can be explained by the Gouy–
Chapman model. In this model, surface potential is inver-
sely proportional to the square root of the monovalent salt
concentration [2]. In contrast to that of tryptamine, the
uptake of indoleacetic acid increased with an increase in
the ionic strength (Fig. 4B). Since the surface potential of
the intestinal BBM originates in the surface negative charge
of the membrane, the increase in the uptake of indoleacetic
acid may be due to a decrease in the electrostatic repulsion
force between the membrane and indoleacetic acid. The
surface negative charge also causes a decrease in local
concentration of indoleacetic acid, which leads through
the dissociation equilibrium, to a decrease in the local
concentration of the unionized form of the drug which is
likely to be the permeating species. The opposite effect will
occur with cationic drugs. These results suggest that the
permeation of tryptamine and indoleacetic acid through a
monolayer of Caco-2 cells is also dependent on the mem-
brane surface potential reflecting change in permeation
through the BBM.
To confirm the changes in the membrane surface potential,
we monitor the fluorescence intensity of ANS, a surface
potential-sensitive probe [13–15] that binds to the BBM
vesicles prepared fromCaco-2 cells in the presence of various
concentrations of potassium gluconate. The results are shown
in Fig. 5. From the ordinate intercept of double reciprocal
Fig. 5. (A) Double reciprocal plots of ANS concentration versus
fluorescence intensity (F.I.) of ANS. Effect of ionic strength on the surface
potential of Caco-2 BBM vesicles. Fluorescence intensities in the presence
of 2.5 mM (o), 25 mM (4), 50 mM (5), and 125 mM (5) of potassium
gluconate. Osmolality was adjusted by adding D-mannitol. Each point
represents the mean of three measurements. (B) Relationship between the
ionic strength (I ) of apical buffer and the maximum fluorescence intensity
(F.I.max) of Caco-2 BBM vesicles.
Table 2
n-Octanol-buffer distribution coefficient and permeability of cationic and
anionic drugs
Cationic drug log Doct Permeability Decrease
2.5 mM K+ 125 mM K+
(%)
Atenolol  2.260 0.293F 0.008 0.093F 0.001 68.4
Chlorpromazine 2.212 6.771F 0.247 5.003F 0.243 26.1
Gramine  0.826 6.263F 0.123 4.599F 0.153 26.6
Imipramine 1.325 8.223F 0.226 6.052F 0.149 26.4
Metoprolol  0.800 4.472F 0.059 3.668F 0.018 18.0
Pheniramine 0.095 4.474F 0.066 3.573F 0.103 20.1
Phenylbutylamine  0.993 7.749F 0.224 5.542F 0.380 28.5
Pindolol  0.756 2.890F 0.039 2.018F 0.056 30.2
Ritodrin  0.407 0.332F 0.008 0.159F 0.003 52.2
Tryptamine  1.445 1.872F 0.067 1.124F 0.014 40.0
Anionic drug log Doct Permeability Increase
2.5 mM K+ 125 mM K+
(%)
Indoleacetic acid 0.000 43.5F 1.3 69.9F 1.5 60.7
Metiazic acid 1.823 89.7F 5.0 110.5F 3.4 23.2
Naproxen 1.557 106.5F 3.0 145.8F 6.4 36.9
Phenylacetic acid  0.187 83.9F 4.3 116.6F 8.0 39.1
Phenylbutylic acid 1.069 185.2F 4.2 236.0F 4.9 27.4
Salicylic acid 0.198 41.7F 1.6 75.8F 2.1 81.8
Tolmetin 1.394 46.2F 0.8 66.3F 0.4 43.5
Distribution coefficient (Doct) was measured at pH 6.0 in the presence of 2.5
mM K+ . The unit of permeability is  10 6 cm/s. Each value represents
the meanF S.E. of three measurements.
Fig. 4. Relationships between the uptake of tryptamine (A) and indoleacetic
acid (B) and ionic strength of the apical buffer. The concentrations of
tryptamine and indoleacetic acid were 500 AM. Ionic strength varied with
changes in the concentration of potassium gluconate (2.5, 25, 50, and 125
mM), and osmolality was adjusted by adding D-mannitol. Each point
represents the meanF S.E. of three measurements.
Fig. 6. Relationships between permeability across Caco-2 cells and effects
of membrane surface potential on the transport of (A) cationic and (B)
anionic drugs. Permeability in the presence of 2.5 mM potassium in Table 2
was used.
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plots of fluorescence intensity against ANS concentration,
maximum fluorescence intensity, F.I.max, was calculated (Fig.
5A). As shown in Fig. 5B, F.I.max increased with increase in
ionic strength. These results suggest that the change in the
concentration of potassium gluconate in this study causes a
significant change in the membrane surface potential.
Davis et al. [16] reported that ion pair formation with
cationic ions, such as Na + and K + , is a major mechanism
of the good intestinal absorption of proxicromil, a strongly
acidic antiallergy agent. They showed that the n-octanol-
buffer distribution coefficients increased with increase in the
cation concentration (ionic strength). On the other hand,
Austin et al. [17] reported that ion pair formation was
insignificant in the binding of proxicromil to dioleoylphos-
phatidylcholine liposomes even though n-octanol-buffer
distribution coefficient was increased with increase of ionic
strength. Moreover, Alcorn et al. [18] reported the results
that did not support the concept of ion-pairing enhancing
absorption via increased extraction into membranes. Fur-
thermore, ion-pair formation cannot explain the decrease of
the uptake or the permeation of tryptamine by an increase in
ionic strength. Therefore, ion-pair formation is not likely the
primary mechanism underlying the changes in the uptake
and the permeation of these compounds.
3.5. Generality of the effect of ionic strength on the
permeation of drugs
In order to determine the generality of the effect of ionic
strength on the permeation of cationic and anionic com-
pounds across a monolayer of Caco-2 cells, we measured the
permeation rates of ten cationic compounds and seven
anionic compounds. This transport study was carried out in
the presence of 2.5 or 125 mM of potassium ions (i.e., two
different ionic strength conditions). As shown in Table 2, the
permeation rates of all of the tested cationic compounds
decreased, whereas those of the anionic compounds
increased. Moreover, no differences were found in the
permeation rates of neutral (acetanilide, antipyrine, and
caffeine) and zwitterionic (enoxacin) drugs in the presence
of 2.5 mM and in the presence of 125 mM of potassium (not
shown). These results suggest that decreases and increases in
the permeation rates of cationic and anionic compounds due
to changes in the ionic strength are common in the respective
groups of drugs. The percentages of decreases in the per-
meation rates of cationic compounds and increases in the
permeation rates of anionic compounds with increase in the
concentration of K + from 2.5 to 125 mM are shown in Table
2. The degrees of the effects of ionic strength on the
permeation rates of the tested compounds varied.
3.6. Relationship between effect of ionic strength and
permeation rates of drugs
Fig. 6 shows the relationship between effects of ionic
strength on permeation through the monolayer of Caco-2
cells (Table 2) and permeation rates of cationic (Fig. 6A)
and anionic (Fig. 6B) compounds in the presence of 2.5 mM
of potassium ions (Table 2). As shown in Fig. 6, the
compound that showed a relatively lower permeation rate
was given stronger effect. Fig. 7 shows plots of the decrease
and increase in the permeation rate versus n-octanol-buffer
distribution coefficient (Doct) of the tested drugs (Table 2).
There was no particular relationship except for a tendency
for the effect on lopophilic drugs to be relatively small. In
this study, we did not examine in further detail the relation-
ships between physicochemical properties and permeation
rates of the drugs.
In conclusion, the results in this study suggest that the
electrostatic interaction caused by change in potassium ion
concentration rather than by change in transmembrane
electric potential difference is the dominant effect. The
effects on the permeation rates of cationic and anionic drugs
were opposite. We do not know the reason why the com-
pound that showed a relatively lower permeation rate was
given stronger effect. However, the possibility of over-
estimation or underestimation caused by these effects should
be considered when the permeation of an ionic compound is
evaluated using a cell monolayer system.
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